secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kaya Holdings, Inc. (KAYS)
CIK:        0001530746
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001903596-23-000077
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kaya Holdings launches Fifth Dimension Therapeutics to enter psychedelic treatment market
--------------------------------------------------------------------------------

- Fifth Dimension Therapeutics will target PTSD, addiction, eating disorders, and treatment-resistant mental health conditions.
- Employee Bryan Arnold enrolled in Oregon Psilocybin Facilitator training; expected to complete and apply for license in April 2023.
- Attorney Glenn E.J. Murphy joins FDT board to assist with pharma partnerships, IP, and funding opportunities.
- Company cites $2.8B U.S. psychedelics market in 2021, forecast to reach $8.9B by 2029.
- KAYS shifts cannabis focus to Europe while launching psychedelic 'mind care' operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530746/000190359623000077/0001903596-23-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530746/000190359623000077/f2skays8k012723.htm
  HTML page:      https://secwatch.observer/filing/0001903596-23-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer